You are here

Coronary Intervention & Surgery

 

A randomized trial found that patients had similar rates of survival and quality of life whether they underwent elective open and endovascular repair of their aortic abdominal aneurysm (AAA). The procedures also had similar costs and cost-effectiveness ratios.

A new transcatheter aortic valve implantation (TAVI) by Boston Scientific has received market approval in Europe.

Children typically have chronic kidney disease and hypertension five years after undergoing cardiac surgery, according to a prospective, multicenter cohort study. The outcomes were similar whether or not children had perioperative acute kidney injury.

The Cardiovascular Research Foundation has announced the lineup of late-breaking clinical trials and first report investigations for the upcoming Transcatheter Cardiovascular Therapeutics (TCT) conference.

Nearly 75 percent of cardiothoracic surgeons are satisfied with their current career, according to a survey from the Society of Thoracic Surgeons (STS). The findings showed that 14.9 percent were extremely satisfied, 28.6 percent were very satisfied, 29.3 percent were satisfied, 21.3 percent were somewhat satisfied and 5.9 percent were not at all satisfied.

 

 

Recent Headlines

Early detection, surgery shorten recovery time for stroke victims

Time and surgery are of the essence when it comes to stroke treatment. A study published in the Sept. 27 issue of JAMA found that earlier treatment with endovascular thrombectomy plus medical therapy was associated with less disability after three months.

Parasitic heart disease threat creeps into U.S.

Chagas heart disease is common in Latin America. Now, given the growing immigrant population, U.S. physicians need to know how to recognize and treat it. 

Women on the heart transplant list face a greater risk of death

Women on the heart transplant list are more likely than their male counterparts to die while waiting for a heart transplant, according to a poster presented at the Heart Failure Society of America Scientific Assembly.

Developing infective endocarditis following TAVR is associated with high mortality rates

Patients who developed infective endocarditis after undergoing transcatheter aortic valve replacement (TAVR) had high rates of morbidity and mortality, according to a registry analysis. The in-hospital mortality rate was 36 percent, while the two-year mortality rate was 66.7 percent.

Open and endovascular AAA repair have similar cost-effectiveness and survival rates

A randomized trial found that patients had similar rates of survival and quality of life whether they underwent elective open and endovascular repair of their aortic abdominal aneurysm (AAA). The procedures also had similar costs and cost-effectiveness ratios.

Coronary angiography, PCI use following out-of-hospital cardiac arrest increases from 2000 to 2012

After an out-of-hospital cardiac arrest, the use of coronary angiography and PCI increased from 2000 to 2012 among patients with initial rhythms of ventricular tachycardia or pulseless ventricular fibrillation (VT/VF), according to an observational analysis. There was also an improvement in survival to hospital discharge and discharge home.

Alternative to high risk surgery? New TAVI device approved in Europe

A new transcatheter aortic valve implantation (TAVI) by Boston Scientific has received market approval in Europe.

New sound therapy can reduce blood pressure in hypertensive patients

A new noninvasive neurotechnology has been shown to lower blood pressure, improve heart rate variability and reduced migraine symptoms.

Chronic kidney disease, hypertension are common after children undergo cardiac surgery

Children typically have chronic kidney disease and hypertension five years after undergoing cardiac surgery, according to a prospective, multicenter cohort study. The outcomes were similar whether or not children had perioperative acute kidney injury.

Probiotics do the heart good

In case Jamie Lee Curtis’ Activia advertisements praising the health benefits of probiotics wasn’t enough, new research suggests that the live bacteria and yeast may one day aid in the treatment of pulmonary hypertension.

Pages